Correlation Engine 2.0
Clear Search sequence regions


  • acid (4)
  • ASAH1 (4)
  • ceramides (1)
  • exon (1)
  • farber disease (5)
  • fibroblasts (1)
  • human (2)
  • patient (3)
  • protein human (1)
  • stem cell (4)
  • subunit (1)
  • Sizes of these terms reflect their relevance to your search.

    Farber disease is an ultra-rare lysosomal storage disease. Mutations in the N-acylsphingosine amidohydrolase (ASAH1) gene, which encodes for the enzyme acid ceramidase (ACDase), cause ceramides to accumulate in the body. A human induced pluripotent stem cell (iPSC) line TRNDi030-A was generated from fibroblasts of a male patient with a homozygous p. Y36C (c.107 A>G) variant in the second exon of the ASAH1 producing the alpha subunit of ACDase. This Farber disease iPSC line is a useful resource to study disease pathophysiology and to develop therapeutics for treatment of patients with Farber disease. Copyright © 2021. Published by Elsevier B.V.

    Citation

    Brianna M Brooks, Charles D Yeh, Jeanette Beers, Chengyu Liu, Yu-Shan Cheng, Kirill Gorshkov, Jizhong Zou, Wei Zheng, Catherine Z Chen. Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1. Stem cell research. 2021 May;53:102387

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34088014

    View Full Text